citalopram has been researched along with nomifensine in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (19.05) | 18.7374 |
1990's | 3 (14.29) | 18.2507 |
2000's | 6 (28.57) | 29.6817 |
2010's | 7 (33.33) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gibb, JW; Hanson, GR; Ritter, JK; Schmidt, CJ | 1 |
Campbell, IC; Ellison, DW | 1 |
Ostrow, D | 1 |
Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
Bonhomme, N; De Deurwaerdère, P; Le Moal, M; Spampinato, U | 1 |
Gerhardt, GA; Hebert, MA | 2 |
Cubeddu, LX; Suarez-Roca, H | 1 |
Adkins, EM; Blakely, RD; Field, JR; Henry, LK; Newman, AH; Parnas, ML; Vaughan, RA; Zou, MF | 1 |
Itakura, C; Katayama, M; Niimi, K; Takahashi, E | 1 |
Nikiforuk, A; Popik, P | 1 |
Blier, P; El Mansari, M; Jiang, JL | 1 |
2 review(s) available for citalopram and nomifensine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
2 trial(s) available for citalopram and nomifensine
Article | Year |
---|---|
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
18 other study(ies) available for citalopram and nomifensine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Dopamine-mediated increases in nigral substance P-like immunoreactivity.
Topics: Animals; Citalopram; Clomipramine; Corpus Striatum; Dopamine; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Nomifensine; Propylamines; Radioimmunoassay; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substance P; Substantia Nigra | 1985 |
Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzylamines; Cerebral Cortex; Citalopram; Clonidine; Clorgyline; Desipramine; Hydroxyindoleacetic Acid; Male; Maprotiline; Nomifensine; Potassium; Propylamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Synaptosomes; Yohimbine | 1986 |
d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Anesthesia; Animals; Citalopram; Corpus Striatum; Dialysis; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fenfluramine; Halothane; Hydroxyindoleacetic Acid; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Serotonin; Tetrodotoxin | 1995 |
Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Aging; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Corpus Striatum; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Electrochemistry; Habituation, Psychophysiologic; Limbic System; Locomotion; Male; Nomifensine; Nucleus Accumbens; Potassium; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Substantia Nigra | 1998 |
Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study.
Topics: Adrenergic Uptake Inhibitors; Aging; Animals; Citalopram; Corpus Striatum; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Electrophysiology; Male; Nomifensine; Nucleus Accumbens; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors | 1999 |
The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals.
Topics: Animals; Binding, Competitive; Catecholamines; Citalopram; Dopamine; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Nerve Endings; Nomifensine; Norepinephrine; Olfactory Bulb; Rabbits; Selective Serotonin Reuptake Inhibitors; Serotonin | 2002 |
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amino Acid Sequence; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blotting, Western; Cadmium; Cell Line; Cell Membrane; Citalopram; Clomipramine; Cocaine; Cysteine; Dopamine Uptake Inhibitors; Fluoxetine; HeLa Cells; Humans; Immunoprecipitation; Isoleucine; Kinetics; LLC-PK1 Cells; Mazindol; Methionine; Mice; Models, Chemical; Molecular Sequence Data; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Nomifensine; Protein Binding; Protein Structure, Tertiary; Protein Transport; Radiopharmaceuticals; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Stereoisomerism; Substrate Specificity; Tyrosine | 2006 |
Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Mice, Inbred CBA; Models, Animal; Morpholines; Motor Activity; Nomifensine; Piperidines; Pyrazoles; Reboxetine; Receptor, Cannabinoid, CB1; Rimonabant; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2008 |
Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.
Topics: Animals; Antidepressive Agents; Attention; Behavior, Animal; Citalopram; Cognition Disorders; Desipramine; Drug Administration Schedule; Fluoxetine; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Stress, Psychological; Time Factors | 2011 |
Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α
Topics: Adrenergic Uptake Inhibitors; Animals; CA3 Region, Hippocampal; Citalopram; Dopamine; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Hippocampus; Male; Nomifensine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Synaptic Transmission | 2020 |